Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenuePayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coya Therapeutics (COYA) Accumulated Expenses (2022 - 2025)

Historic Accumulated Expenses for Coya Therapeutics (COYA) over the last 4 years, with Q3 2025 value amounting to $1.6 million.

  • Coya Therapeutics' Accumulated Expenses rose 1628.34% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 1628.34%. This contributed to the annual value of $1.4 million for FY2024, which is 5331.45% down from last year.
  • As of Q3 2025, Coya Therapeutics' Accumulated Expenses stood at $1.6 million, which was up 1628.34% from $2.8 million recorded in Q2 2025.
  • In the past 5 years, Coya Therapeutics' Accumulated Expenses registered a high of $3.0 million during Q4 2023, and its lowest value of $724687.0 during Q1 2023.
  • Over the past 4 years, Coya Therapeutics' median Accumulated Expenses value was $1.5 million (recorded in 2024), while the average stood at $1.7 million.
  • In the last 5 years, Coya Therapeutics' Accumulated Expenses tumbled by 5331.45% in 2024 and then skyrocketed by 18294.81% in 2025.
  • Quarter analysis of 4 years shows Coya Therapeutics' Accumulated Expenses stood at $2.0 million in 2022, then surged by 48.04% to $3.0 million in 2023, then plummeted by 53.31% to $1.4 million in 2024, then increased by 18.06% to $1.6 million in 2025.
  • Its last three reported values are $1.6 million in Q3 2025, $2.8 million for Q2 2025, and $1.8 million during Q1 2025.